UBS 'Looking Elsewhere,' Says To Sell Regeneron
July 09, 2015 at 08:55 AM EDT
In a report published Thursday, UBS analyst Matthew Roden downgraded the rating on Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.